{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:25:50Z","timestamp":1773901550363,"version":"3.50.1"},"reference-count":37,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK56942-09"],"award-info":[{"award-number":["DK56942-09"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We previously found that short-term treatment (week 8 to 12 after injury) with high-dose angiotensin receptor blocker (ARB) induced the regression of existing glomerulosclerosis in 5\/6 nephrectomy rats. We therefore assessed the effects of long-term intervention with ARB vs. nonspecific antihypertensives in this study. Adult rats underwent 5\/6 nephrectomy and renal biopsy 8 weeks later. The rats were then divided into three groups with equivalent renal function and glomerular sclerosis and treated with high-dose losartan (ARB), nonspecific antihypertensive triple-therapy (TRX), or left untreated (Control) until week 30. We found that blood pressure, serum creatinine levels, and glomerulosclerosis were lower at sacrifice in ARB and TRX vs. Control. Only ARB reduced proteinuria and maintained the density of WT-1-positive podocytes. Glomerular tufts showed more double-positive cells for CD44, a marker of activated parietal epithelial cells, and synaptopodin after ARB vs. TRX or Control. ARB treatment reduced aldosterone levels. ARB-treated rats had significantly improved survival when compared with TRX or Control. We conclude that both long-term ARB and triple-therapy ameliorate progression, but do not sustain the regression of glomerulosclerosis. ARB resulted in the superior preservation of podocyte integrity and decreased proteinuria and aldosterone, linked to increased survival in the uremic environment.<\/jats:p>","DOI":"10.3390\/ijms23116018","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T07:05:07Z","timestamp":1653635107000},"page":"6018","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker"],"prefix":"10.3390","volume":"23","author":[{"given":"Xuejing","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Nephrology, Second Xiangya Hospital, Central South University, Changsha 410011, China"},{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Department of Nephrology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Albertazzi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Unit of Nephrology and Dialysis, \u201cGuglielmo da Saliceto\u201d AUSL Piacenza Hospital, Via Taverna 49, 29100 Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Division of Pediatric Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[{"name":"Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Shyr","sequence":"additional","affiliation":[{"name":"Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-0205","authenticated-orcid":false,"given":"Valentina","family":"Kon","sequence":"additional","affiliation":[{"name":"Division of Pediatric Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4265-7492","authenticated-orcid":false,"given":"Hai-Chun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Division of Pediatric Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes B.","family":"Fogo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Division of Pediatric Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"},{"name":"Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1681\/ASN.2011050456","article-title":"Kidney function can improve in patients with hypertensive CKD","volume":"23","author":"Hu","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Weis, L., Metzger, M., Haymann, J.P., Thervet, E., Flamant, M., Vrtovsnik, F., Gauci, C., Houillier, P., Froissart, M., and Letavernier, E. (2013). Renal function can improve at any stage of chronic kidney disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081835"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000500925","article-title":"Is chronic kidney disease progression influenced by the type of renin-angiotensin-system blocker used?","volume":"143","author":"Silvarino","year":"2019","journal-title":"Nephron"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1681\/ASN.V105997","article-title":"In chronic nephropathies prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR","volume":"10","author":"Ruggenenti","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2004060492","article-title":"Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1","volume":"16","author":"Ma","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/01.ASN.0000095248.91994.D3","article-title":"Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats","volume":"14","author":"Adamczak","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1097\/01.ASN.0000146121.72699.86","article-title":"Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature","volume":"15","author":"Adamczak","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/1470320314543910","article-title":"ACE-inhibition increases podocyte number in experimental glomerular disease independent of proliferation","volume":"16","author":"Zhang","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1681\/ASN.2015080877","article-title":"Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage","volume":"27","author":"Lichtnekert","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1159\/000342808","article-title":"Retinoids augment the expression of podocyte proteins by glomerular parietal epithelial cells in experimental glomerular disease","volume":"121","author":"Zhang","year":"2012","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1681\/ASN.2012050445","article-title":"Reversibility of structural and functional damage in a model of advanced diabetic nephropathy","volume":"24","author":"Pichaiwong","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI36703","article-title":"Disruption of the Ang II type 1 receptor promotes longevity in mice","volume":"119","author":"Benigni","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11357-012-9408-8","article-title":"Variations of the angiotensin II type 1 receptor gene are associated with extreme human longevity","volume":"35","author":"Benigni","year":"2013","journal-title":"Age"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/ncomms2240","article-title":"Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart","volume":"3","author":"Xie","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1681\/ASN.2006010089","article-title":"Isolation and characterization of multipotent progenitor cells from the Bowman\u2019s capsule of adult human kidneys","volume":"17","author":"Sagrinati","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajpath.2011.04.003","article-title":"Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture","volume":"179","author":"Benigni","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ajpath.2013.08.008","article-title":"Nature and mediators of parietal epithelial cell activation in glomerulonephritides of human and rat","volume":"183","author":"Rizzo","year":"2013","journal-title":"Am. J. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Arias, S.C., Valente, C.P., Machado, F.G., Fanelli, C., Origassa, C.S., de Brito, T., Camara, N.O., Malheiros, D.M., Zatz, R., and Fujihara, C.K. (2013). Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056215"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e1999","DOI":"10.1097\/MD.0000000000001999","article-title":"The association of losartan and ramipril therapy with kidney and cardiovascular outcomes in patients with chronic kidney disease: A Chinese nation-wide cohort study in Taiwan","volume":"94","author":"Hsing","year":"2015","journal-title":"Medicine"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","article-title":"Role of remission clinics in the longitudinal treatment of CKD","volume":"19","author":"Ruggenenti","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1681\/ASN.2014070688","article-title":"Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis","volume":"26","author":"Heerspink","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"Remuzzi","year":"2004","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1093\/ndt\/gfq848","article-title":"The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men","volume":"26","author":"Nerpin","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): A randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1093\/eurheartj\/ehn383","article-title":"Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction","volume":"29","author":"Palmer","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1753944719868134","DOI":"10.1177\/1753944719868134","article-title":"The place of ARBs in heart failure therapy: Is aldosterone suppression the key?","volume":"13","author":"Markan","year":"2019","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8116","DOI":"10.1038\/srep08116","article-title":"Suppression of adrenal betaarrestin1-dependent aldosterone production by ARBs: Head-to-head comparison","volume":"5","author":"Dabul","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.2011040430","article-title":"Sodium intake, ACE inhibition, and progression to ESRD","volume":"23","author":"Vegter","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/labinvest.2016.42","article-title":"Effects of combination PPARgamma agonist and angiotensin receptor blocker on glomerulosclerosis","volume":"96","author":"Matsushita","year":"2016","journal-title":"Lab. Investig."},{"key":"ref_35","first-page":"647","article-title":"Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis","volume":"21","author":"Liu","year":"2021","journal-title":"Med. Clin."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1172\/JCI112528","article-title":"Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat","volume":"77","author":"Anderson","year":"1986","journal-title":"J. Clin. Investig."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Stefanon, I., Valero-Munoz, M., Fernandes, A.A., Ribeiro, R.F., Rodriguez, C., Miana, M., Martinez-Gonzalez, J., Spalenza, J.S., Lahera, V., and Vassallo, P.F. (2013). Left and right ventricle late remodeling following myocardial infarction in rats. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064986"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6018\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:19:37Z","timestamp":1760138377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/11\/6018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijms23116018"],"URL":"https:\/\/doi.org\/10.3390\/ijms23116018","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}